Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Cadila Healthcare submits disclosure
Date: 26-12-2013Cadila Healthcare has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
The above information is a part of company’s filings submitted to BSE.